Four common glomulin mutations cause two-thirds of glomuvenous malformations ("familial glomangiomas"):: evidence for a founder effect -: art. no. e13

被引:80
作者
Brouillard, P
Ghassibé, M
Penington, A
Boon, LM
Dompmartin, A
Temple, IK
Cordisco, M
Adams, D
Piette, F
Harper, JI
Syed, S
Boralevi, F
Taïeb, A
Danda, S
Baselga, E
Enjolras, O
Mulliken, JB
Vikkula, M
机构
[1] Univ Cincinnati, Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH 45221 USA
[2] Ctr Hosp Reg & Univ Lille, Dermatol Clin, F-59037 Lille, France
[3] Great Ormond St Hosp Children NHS Trust, London WC1N 3JH, England
[4] CHU, Hop Pellegrin Enfants, Unite Dermatol Pediat, Bordeaux, France
[5] Womens & Childrens Hosp, S Australian Clin Genet Serv, Adelaide, SA, Australia
[6] Univ Autonoma Barcelona, Hosp Santa Cruz & San Pablo, Dept Dermatol, E-08193 Barcelona, Spain
[7] Hop Lariboisiere, F-75475 Paris, France
[8] Harvard Univ, Sch Med, Div Plast Surg, Vascular Anomalies Ctr,Childrens Hosp, Boston, MA USA
关键词
D O I
10.1136/jmg.2004.024174
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Glomuvenous malformation (GVM) ("familial glomangioma'') is a localised cutaneous vascular lesion histologically characterised by abnormal smooth muscle-like "glomus cells'' in the walls of distended endothelium lined channels. Inheritable GVM has been linked to chromosome 1p21-22 and is caused by truncating mutations in glomulin. A double hit mutation was identified in one lesion. This finding suggests that GVM results from complete localised loss of function and explains the paradominant mode of inheritance. Objective: To report on the identification of a mutation in glomulin in 23 additional families with GVM. Results: Three mutations are new; the others have been described previously. Among the 17 different inherited mutations in glomulin known up to now in 43 families, the 157delAAGAA mutation is the most common and was present in 21 families (48.8%). Mutation 108C-->A was found in five families (11.8%), and the mutations 554delA+ 556delCCT and 1179delCAA were present together in two families (4.7% each). Polymorphic markers suggested a founder effect for all four mutations. Conclusions: Screening for these mutations should lead to a genetic diagnosis in about 70% of patients with inherited GVM. So far, a mutation in glomulin has been found in all GVM families tested, thus demonstrating locus homogeneity.
引用
收藏
页数:8
相关论文
共 27 条
[1]   Targeted disruption of p185/Cul7 gene results in abnormal vascular morphogenesis [J].
Arai, T ;
Kasper, JS ;
Skaar, JR ;
Ali, SH ;
Takahashi, C ;
DeCaprio, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (17) :9855-9860
[2]   A gene for inherited cutaneous venous anomalies ("glomangiomas") localizes to chromosome 1p21-22 [J].
Boon, LM ;
Brouillard, P ;
Irrthum, A ;
Karttunen, L ;
Warman, ML ;
Rudolph, R ;
Mulliken, JB ;
Olsen, BR ;
Vikkula, M .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (01) :125-133
[3]   Glomuvenous malformation (Glomangioma) and venous malformation - Distinct clinicopathologic and genetic entities [J].
Boon, LM ;
Mulliken, JB ;
Enjolras, O ;
Vikkula, M .
ARCHIVES OF DERMATOLOGY, 2004, 140 (08) :971-976
[4]   High-resolution physical and transcript map of the locus for venous malformations with glomus cells (VMGLOM) on chromosome 1p21-p22 [J].
Brouillard, P ;
Olsen, BR ;
Vikkula, M .
GENOMICS, 2000, 67 (01) :96-101
[5]   Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ("glomangiomas") [J].
Brouillard, P ;
Boon, LM ;
Mulliken, JB ;
Enjolras, O ;
Ghassibé, M ;
Warman, ML ;
Tan, OT ;
Olsen, BR ;
Vikkula, M .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (04) :866-874
[6]   Vascular malformations: localized defects in vascular morphogenesis [J].
Brouillard, P ;
Vikkula, M .
CLINICAL GENETICS, 2003, 63 (05) :340-351
[7]   Additional glomangioma families link to chromosome 1p: No evidence for genetic heterogeneity [J].
Calvert, JT ;
Burns, S ;
Riney, TJ ;
Sahoo, T ;
Orlow, SJ ;
Nevin, NC ;
Haisley-Royster, C ;
Prose, N ;
Simpson, SA ;
Speer, MC ;
Marchuk, DA .
HUMAN HEREDITY, 2001, 51 (03) :180-182
[8]   Spectrum and expression analysis of KRIT1 mutations in 121 consecutive and unrelated patients with Cerebral Cavernous Malformations [J].
Cavé-Riant, F ;
Denier, C ;
Labauge, P ;
Cécillon, M ;
Maciazek, J ;
Joutel, A ;
Couteulx, SLL ;
Tournier-Lasserve, E .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 (11) :733-740
[9]   FAP48, a new protein that forms specific complexes both immunophilins FKBP59 and FKBP12 - Prevention by the immunosuppressant drugs FK506 and rapamycin [J].
Chambraud, B ;
Radanyi, C ;
Camonis, JH ;
Shazand, K ;
Rajkowski, K ;
Baulieu, EE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (51) :32923-32929
[10]   Mechanism of TGF beta receptor inhibition by FKBP12 [J].
Chen, YG ;
Liu, F ;
Massague, J .
EMBO JOURNAL, 1997, 16 (13) :3866-3876